Full Protocol 3: Opioid Use, Misuse, and Addiction in Pregnancy and Postpartum

Publication
Article
Contemporary OB/GYN JournalVol 66 No 3
Volume 66
Issue 03

This is the complete chapter on opioids in pregnancy and postpartum from Protocols for High-Risk Pregnancies, 7th Edition, edited by John T. Queenan, MD, Catherine Y. Spong, MD, and Charles J. Lockwood, MD, MHCM.

Protocol 3: Opioid Use, Misuse, and Addiction in Pregnancy and Postpartum

Read the snapshot here: Snapshot: Protocol 3 - Opioid Use, Misuse, and Addiction in Pregnancy and Postpartum

Download Issue PDF
Articles in this issue
Was a Hysterectomy and Bilateral Salpingo-oophorectomy Necessary?
Was a Hysterectomy and Bilateral Salpingo-oophorectomy Necessary?
Full Protocol 3: Opioid Use, Misuse, and Addiction in Pregnancy and Postpartum
Full Protocol 3: Opioid Use, Misuse, and Addiction in Pregnancy and Postpartum
Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restriction
Summary of Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and management of fetal growth restriction
Snapshot: Protocol 3 - Opioid Use, Misuse, and Addiction in Pregnancy and Postpartum
Snapshot: Protocol 3 - Opioid Use, Misuse, and Addiction in Pregnancy and Postpartum
A Missed Opportunity
A Missed Opportunity
Tools and strategies to improve outcomes for perinatal opioid use disorder
Tools and strategies to improve outcomes for perinatal opioid use disorder
Inclusion necessary in clinical trials
Inclusion necessary in clinical trials
Genitourinary Syndrome of Menopause is Overlooked and Undertreated
Genitourinary Syndrome of Menopause is Overlooked and Undertreated
Inflammatory mediators and pain in endometriosis
Inflammatory mediators and pain in endometriosis
Menopausal symptoms associated with premature ovarian insufficiency
Menopausal symptoms associated with premature ovarian insufficiency
Augmenting/replacing obstetric comorbidity index with L&D features
Augmenting/replacing obstetric comorbidity index with L&D features
Severity of COVID-19 Determines Likelihood of Pregnancy Complications
Severity of COVID-19 Determines Likelihood of Pregnancy Complications
Opioids and Obstetrics: Substance use disorders in pregnancy
Opioids and Obstetrics: Substance use disorders in pregnancy
Rally for Maternal Health
Rally for Maternal Health
Contraceptive counseling via volunteer reproductive health educators
Contraceptive counseling via volunteer reproductive health educators
Recent Videos
Barbed suture reduces blood loss in hysterectomy | Image Credit: linkedin.com
Integrase inhibitors not linked to neonatal weight | Image Credit: linkedin.com
How AI is revolutionizing prenatal detection of congenital heart defects | Image Credit: mfmnyc.com/team.
Dr. Wennerholm highlights future opportunities for managing prolonged pregnancy | Image Credit: gu.se/en/about/find-staff.
Swedish study highlights reduced risks from active prolonged pregnancy management | Image Credit: gu.se/en/about/find-staff.
New guidelines show better outcomes for managing hematological malignancies in pregnancy | Image Credit: isom-somanz2024.org.
How embryo testing reduces miscarriages and enhances IVF success | Image Credit: havingbabies.com.
Contraceptive trends indicate reduced hormone use and rise in natural methods | Image Credit: x.com.
Radon exposure linked to increased risk of gestational diabetes | Image Credit: publichealth.columbia.edu.
Worse menopause symptom burden reported in rural women | Image Credit: uwmedicine.org.
Related Content
Image Credit: © luckakcul - stock.adobe.com

Microplastics and nanoplastics found in higher concentrations in preterm placentas

Morgan Ebert, Managing Editor
January 30th 2025
Article

Read More

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Celeste Krewson, Assistant Editor
December 31st 2024
Podcast

In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

Listen

Gameto's Fertilo investigational product made of ovarian support cells (OSCs) in a vial. Photo credit: Gameto

FDA grants clearance for phase 3 trial of Fertilo, an iPSC-based fertility treatment

Morgan Ebert, Managing Editor
January 30th 2025
Article

Gameto’s Fertilo gets FDA clearance for a phase 3 trial, pioneering iPSC-based fertility treatment to shorten IVF cycles and improve reproductive care.

Read More

Site Logo

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

September 29th 2023
Podcast

Listen

Call for abstract, workshop, and roundtable submissions for PFD Week 2025

Call for abstract, workshop, and roundtable submissions for PFD Week 2025

American Urogynecologic Society (AUGS)
January 29th 2025
Article

Submit your abstract and/or roundtable and workshop proposal for PFD Week 2025, to be held October 14-17 in Vancouver, Canada!

Read More

Take charge of 2025: A financial webinar series for physicians

Take charge of 2025: A financial webinar series for physicians

American Urogynecologic Society (AUGS)
January 29th 2025
Article

We're excited to announce a new four-part webinar series designed to educate and empower physicians with financial tools and insights needed to prosper in 2025 and beyond.

Read More

© 2025 MJH Life Sciences

All rights reserved.